Clinical Trial Update: Ga-68-PSMA-11 in High-risk Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Ga-68-PSMA-11 in high-risk prostate cancer across phase 1 and phase 2 trials; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Ga-68 PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical imaging agent)

Snippet

Sponsor: German Cancer Research Center | Conditions: High-risk Prostate Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED